Back to News
Market Impact: 0.3
Evolent Health, Inc. Reports Third Quarter 2026 Financial Results
Source: Nasdaq
Corporate EarningsCompany Fundamentals
Evolent Health reported revenue of $725.367 million for the three months ended September 30, 2026, up from $479.533 million in the same period of 2025 (approximately 51%). The company also reported a net loss attributable to common shareholders, but the article text is truncated before giving its amount or further results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment
EVH0.10
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Qualcomm slides 9% after earnings, leading post-election chip stock sell-off
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook